Through the commercialization of its proprietary cannabis
cultivation technology, GrowBLOX Sciences, Inc. (OTCQB: GBLX) is building a
formidable presence in the burgeoning medicinal cannabis industry. In order to
capitalize on this position, the company plans to utilize a specialized three
phase retail distribution solution that will allow for comprehensive coverage
of the country’s legalized medicinal cannabis markets.
Phase one of GrowBLOX’s projected retail channel solutions
is The Apothecary. This unique retail environment combines a simple, clean and
clinical design with cutting-edge biometrics and patient verification to ensure
a pleasant and safe customer experience. When visiting The Apothecary, patients
will have access to highly trained and certified patient-care professionals,
who will help determine medical needs and identify therapeutic solutions. Since
doctors have limited training in the benefits of cannabinoid therapy products,
these professionals are essential to the company’s patient education efforts.
For an inside view of The Apothecary, visit https://vimeo.com/129493221.
In order to expand its retail distribution network and
bypassing the costs of traditional brick and mortar locations, GrowBLOX
Sciences will also offer a collection of Micro-Apothecary self-service vending
kiosks, which will serve as phase two of the company’s retail channel
solutions. These machines will provide validated patients with a quick and easy
way to obtain the company’s products. Since the Micro-Apothecary can be
installed in any existing retail location or traditional pharmacy permitted to
sell medical cannabis products or distribute clinical trial medication doses.
This prudent approach offers GBLX a cost-effective method of exponentially
expanding its distribution network in the years to come.
The final phase of the company’s projected retail network is
its innovative mobile app. Set to be released in the second half of 2015, this
powerful tool will allow patients to generate profiles, track symptoms, browse local
inventory options and order products for pickup or delivery through the use of
a mobile device. This mobile app will be essential for tracking valuable
patient data and streamline distribution efforts beyond the bounds of its
physical locations in order to maximize potential growth moving forward.
With a full network of projected retail channel solutions in
place, GBLX is in a solid position to promote strong returns in the future. In
the coming months, look for the company to continue building upon its recent
commercial progress in an effort to maximize market share within the expanding
medicinal cannabis industry.
For more information, visit www.gbsciences.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment